Redmile Group, LLC - 10%+ Owner at ADC Therapeutics SA

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
ADCT on NYSE
All Insider Reports
All Insider Reports

Redmile Group, LLC - trading volume in the past year for ADC Therapeutics SA

Holdings reported by Redmile Group, LLC for ADC Therapeutics SA

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares, par value CHF 0.08 per share 15.7M $59.7M $3.81 Dec 11, 2024 Indirect
Pre-Funded Warrants 15.7M $54M $3.43 Jun 11, 2025 Indirect Common Share
Common Shares, par value CHF 0.08 per share 13.1M $50.1M $3.81 Dec 11, 2024 Direct
Common Shares, par value CHF 0.08 per share 15.7M $44M $2.81 Jul 1, 2024 Indirect
Pre-Funded Warrants 12.5M $42.8M $3.43 Jun 11, 2025 Direct Common Share
Common Shares, par value CHF 0.08 per share 13M $36.5M $2.81 Jul 1, 2024 Direct

Transactions reported by Redmile Group, LLC for ADC Therapeutics SA

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.